avanti polar lipids/Soy Extract Polar/500mg/541602C-500mg,avanti polar lipids,,Avanti Polar,Avanti,avantilipids,Avanti Polar Lipids Inc,品牌试剂实验Avanti Polar代理 Avanti授权代理商，正品,,Array.Array.Array蚂蚁淘厂家直采.

产品名称：avanti polar lipids/Soy Extract Polar/500mg/541602C-500mg

产品编号：541602C-500mg

市场价：¥12800.00

场地：美国(厂家直采)

产品分类：生化试剂>其他>酯>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$640.00

品牌： avanti polar lipids

公司：Avanti Lipids Polar, Inc.

公司分类：

商品介绍

541602 | Soy Extract Polar

Soybean Polar Lipid Extract

Info

Soy Extract Polar

Soybean Polar Lipid Extract

Polar Lipid Extract is derived from the total lipid extract by precipitation with acetone followed by extraction of the acetone insoluble material with diethyl ether.

Data

Hygroscopic

Yes

Light Sensitive

Stability

1 Year

Storage Temperature

-20°C

CAS Number

8030-76-0 CAS Registry Number is a Registered Trademark of the American Chemical Society

Downloads

Phospholipid Profile
Safety Data Sheet
Safety Data Sheet

References

Zheng X, Fu Z, Su D, Zhang Y, Li M, Pan Y, Li H, Li S, Grassucci RA, Ren Z, Hu Z, Li X, Zhou M, Li G, Frank J, Yang J. Mechanism of ligand activation of a eukaryotic cyclic nucleotide-gated channel. Nat Struct Mol Biol. 2020 Jul;27(7):625-634. doi: 10.1038/s41594-020-0433-5. Epub 2020 Jun 1. PMID: 32483338; PMCID: PMC7354226.

PubMed ID: 32483338

Deng Z, Maksaev G, Rau M, Xie Z, Hu H, Fitzpatrick JAJ, Yuan P. Gating of human TRPV3 in a lipid bilayer. Nat Struct Mol Biol. 2020 Jul;27(7):635-644. doi: 10.1038/s41594-020-0428-2. Epub 2020 Jun 22. PMID: 32572252; PMCID: PMC7354234.

PubMed ID: 32572252

Wang Z, Hu W, Zheng H. Pathogenic siderophore ABC importer YbtPQ adopts a surprising fold of exporter. Sci Adv. 2020 Feb 5;6(6):eaay7997. doi: 10.1126/sciadv.aay7997. PMID: 32076651; PMCID: PMC7002159.

PubMed ID: 32076651

Berg J, Liu J, Svahn E, Ferguson-Miller S, Brzezinski P. Structural changes at the surface of cytochrome c oxidase alter the proton-pumping stoichiometry. Biochim Biophys Acta Bioenerg. 2020 Feb 1;1861(2):148116. doi: 10.1016/j.bbabio.2019.148116. Epub 2019 Nov 14.

PubMed ID: 31733183

Rovini A, Gurnev PA, Beilina A, Queralt-Martín M, Rosencrans W, Cookson MR, Bezrukov SM, Rostovtseva TK. Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC. Cell Mol Life Sci. 2019 Nov 23. doi: 10.1007/s00018-019-03386-w. [Epub ahead of print]

PubMed ID: 31760463

Lin King JV, Emrick JJ, Kelly MJS, Herzig V, King GF, Medzihradszky KF, Julius D. A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain. Cell. 2019 Sep 5;178(6):1362-1374.e16. doi: 10.1016/j.cell.2019.07.014. Epub 2019 Aug 22.

PubMed ID: 31447178

Cheng WWL, Budelier MM, Sugasawa Y, Bergdoll L, Queralt-Martín M, Rosencrans W, Rostovtseva TK, Chen ZW, Abramson J, Krishnan K, Covey DF, Whitelegge JP, Evers AS. Multiple neurosteroid and cholesterol binding sites in voltage-dependent anion channel-1 determined by photo-affinity labeling. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun 5;1864(10):1269-1279. doi: 10.1016/j.bbalip.2019.06.004. [Epub ahead of print]

PubMed ID: 31176038

Baharan Ali Doosti, Weria Pezeshkian, Dennis S. Bruhn John H. Ipsen, Himanshu Khandelia, Gavin D. M. Jeffries, and Tatsiana Lobovkina Membrane Tubulation in Lipid Vesicles Triggered by the Local Application of Calcium Ions. Langmuir, Article ASAP

PubMed ID: 28910109

Certificates of Analysis

Certificate of Analysis(Lot No. 541602C-100MG-A-049and 5051CLA049)
Certificate of Analysis(Lot No. 541602C-1G-A-049and 5051CQA049)
Certificate of Analysis(Lot No. 541602C-500MG-A-049and 5051CPA049)
Certificate of Analysis(Lot No. 541602P-100MG-A-049and 5051PLA049)
Certificate of Analysis(Lot No. 541602P-1G-A-048and 5051PQA048)
Certificate of Analysis(Lot No. 541602P-500MG-A-048and 5051PPA048)
Certificate of Analysis(Lot No. 541602C-100MG-B-049and 5051CLB049)
Certificate of Analysis(Lot No. 541602P-1G-A-050and 5051PQA050)
Certificate of Analysis(Lot No. 541602C-500MG-A-050and 5051CPA050)
Certificate of Analysis(Lot No. 541602P-500MG-A-050and 5051PPA050)
Certificate of Analysis(Lot No. 541602P-100MG-A-050and 5051PLA050)
Certificate of Analysis(Lot No. 541602P-1G-B-050and 5051PQB050)
Certificate of Analysis(Lot No. 541602P-500MG-A-051and 5051PPA051)
Certificate of Analysis(Lot No. 541602P-100MG-A-051and 5051PLA051)
Certificate of Analysis(Lot No. 541602C-100MG-A-051and 5051CLA051)
Certificate of Analysis(Lot No. 541602C-1G-A-051and 5051CQA051)
Certificate of Analysis(Lot No. 541602C-100MG-B-051and 5051CLB051)
Certificate of Analysis(Lot No. 541602C-500MG-A-051and 5051CPA051)
Certificate of Analysis(Lot No. 541602P-1G-A-051and 5051PQA051)
Certificate of Analysis(Lot No. 541602P-1G-A-052and 5051PQA052)
Certificate of Analysis(Lot No. 541602C-500MG-A-052and 5051CPA052)
Certificate of Analysis(Lot No. 541602C-100MG-A-052and 5051CLA052)
Certificate of Analysis(Lot No. 541602C-100MG-B-052and 5051CLB052)
Certificate of Analysis(Lot No. 541602C-1G-A-052and 5051CQA052)
Certificate of Analysis(Lot No. 541602P-500MG-A-053and 5051PPA053)
Certificate of Analysis(Lot No. 541602C-1G-B-052and 5051CQB052)
Certificate of Analysis(Lot No. 541602P-100MG-A-053and 5051PLA053)
Certificate of Analysis(Lot No. 541602C-100MG-C-052and 5051CLC052)
Certificate of Analysis(Lot No. 541602P-500MG-A-052and 5051PPA052)
Certificate of Analysis(Lot No. 541602P-100MG-B-053and 5051PLB053)
Certificate of Analysis(Lot No. 541602C-1G-A-053and 5051CQA053)
Certificate of Analysis(Lot No. 541602C-500MG-A-053and 5051CPA053)
Certificate of Analysis(Lot No. 541602C-1G-B-053and 5051CQB053)
Certificate of Analysis(Lot No. 541602C-100MG-A-053and 5051CLA053)
Certificate of Analysis(Lot No. 541602C-500MG-B-053and 5051CPB053)
Certificate of Analysis(Lot No. 541602C-500MG-C-053and 5051CPC053)
Certificate of Analysis(Lot No. 541602C-100MG-C-053and 5051CLC053)
Certificate of Analysis(Lot No. 541602P-1G-A-053and 5051PQA053)
Certificate of Analysis(Lot No. 541602P-100MG-A-054and 5051PLA054)
Certificate of Analysis(Lot No. 541602P-1G-B-054and 5051PQB054)
Certificate of Analysis(Lot No. 541602C-100MG-C-054and 5051CLC054)
Certificate of Analysis(Lot No. 541602C-500MG-A-056and 5051CPA056)
Certificate of Analysis(Lot No. 541602C-1G-A-056and 5051CQA056)
Certificate of Analysis(Lot No. 541602P-500MG-B-056and 5051PPB056)
Certificate of Analysis(Lot No. 541602C-100MG-B-056and 5051CLB056)
Certificate of Analysis(Lot No. 541602P-100MG-A-056and 5051PLA056)
Certificate of Analysis(Lot No. 541602P-1G-B-056and 5051PQB056)
Certificate of Analysis(Lot No. 541602 C 500 MG B 056and 5051 CPB056)
Certificate of Analysis(Lot No. 541602 C 500 MG B 056and 5051 CPB056)

Base Price:${originalprice|money}

Custom Packaging:(${concentration} @$4.00/ea. + $100)${custompackagingtotal|money}

Packaging:${concentration}

Item Total:${totalprice|money}

(Sales Tax may apply)

Please select an option above.

Selected Product${sku} - ${concentration}

品牌介绍

Avanti Polar Lipids.jpg

Avanti Polar Lipids公司是美国著名的磷脂类产品的生产商，该公司主要为各种制药厂和研究机构提供从毫克级到公斤级乃至吨级的磷脂类和甾体类中间体和试剂。为世界范围内的研究机构和制药公司提供 1000 种以上脂类产品，由于其产品的高纯度而享誉全球。40年来，Avanti Polar Lipids公司为世界各地的研究人员和制药公司提供脂类产品。公司的产品不仅范围日益扩大，其纯度之高也是无人能及。

Avanti Polar Lipids, Inc., has a long history of 50 years creating the highest purity lipids available. Our passion for high quality and unique products is only exceeded by our excellent reputation in the marketplace. Although we are known for our lipids, we are More than Lipids. We offer solutions for the entire product cycle…Research to Commercialization.

Avanti Polar Lipids公司的主要产品和服务包括：

（1）Research Products

Highest Purity Lipid Reagents

（2）cGMP Manufacturing

API & Contract Manufacturing

（3）Adjuvants

Immunotherapy & Vaccine Development

（4）Analytical Services

Lipid Analysis

（5）Lipidomics

Mass Spec Standards, Antibodies & Lipid Toolbox

（6）Formulations